UNSPSC 85813509: Introduction of electrolytic and water balance substance into subcutaneous tissue, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of electrolytic and water balance substance into subcutaneous tissue, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0137Z

UNSPSC 85813509 Introduction of electrolytic and water balance substance into subcutaneous tissue, percutaneous approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code's medical-procedure nomenclature—describing a specific clinical intervention involving subcutaneous injection of electrolytes or hydration therapy—does not match the scope of work actually being solicited by state and local buyers in the opportunities block.

State and local issuing bodies posting under this code are pursuing contracts for broader healthcare service delivery, not the narrow procedural intervention the code nominally describes. Inland Empire Health Plan (IEHP) in California posted an RFI (Solicitation 2607426) on October 16, 2026, seeking 24/7/365 virtual urgent care services with response due October 31, 2026—a telehealth evaluation and management scope bearing no resemblance to subcutaneous electrolyte therapy. DeKalb County, Georgia (RFP PE64400NONST2026000000289, due November 12, 2026) and the Nevada Health Authority (RFP 41NHA-S4038 for PACE operations, due December 10, 2026) solicited medical services of much broader scope. The mismatch suggests either a coding error at the source or that this Commodity code is rarely used for actual state and local procurement. The code shows no meaningful recent activity grounded in the work state and local governments are actually buying.